Synovial fluid (SF) cytology when applied to a group of rheumatoid joints with active synovitis shows a heterogeneous picture in terms of total white cell count and in the proportions of polymorphs, mononuclear cells, and ragocytes'-3 (ragocytes being leucocytes with intracytoplasmic granules recognised in a wet smear of synovial fluid4 5) . This variation is extreme with the total white cell range being 3-200x 109/1,6 and in the case of ragocytes from 3% to 97% of the leucocyte population. 4 Polymorphonuclear cells predominate in most rheumatoid synovial effusions from inflamed joints.
There have been case reports suggesting that when SF is studied sequentially from joints over a period of time or from several joints in the same patient at one time that the SF cytological findings are more homogeneous in that joint or patient. 
Results
Seventy seven SF samples from 50 joints (47 knees, two elbows, one shoulder) were examined, 27 joints were aspirated twice. The interval between aspirations in these 27 joints varied from one to 18 months (median nine months) with treatment regimens being unaltered for 20 of these joints. In all but two of the 27 joints the interval between aspiration was three or more months. A variety of treatment regimens had been used, but all patients had been taking their respective second line drug for at least three months before the first aspiration.
Synovial fluid cytology at the two times was compared in these 27 joints. Positive correlations between proportions, though not absolute numbers, of polymorphs and ragocytes were found at the times of the two aspirations (correlation coefficient r=068 and 0-73 respectively, 
was more significant when only joints in which the treatment was unchanged between aspirations were included (r=0-82 and 087, Fig. lb) . No correlation was found between total white cell count and the proportion of polymorphs and ragocytes, excluding this as a source of bias. The correlation remained significant for both polymorphs and ragocytes if the two joints whose time interval between reaspiration was less than three months were excluded from the analysis.
Comparison of SF cytology in 17 patients who had separate inflamed joints aspirated at different times during the study showed no correlation between the various cell types (r=0-37 for polymorphs and 0-19 for ragocytes, Fig. lc ). In addition, four patients had both knees aspirated on two occasions during the study. The results were similar in the SF cytology in each knee over time, but there was no similarity between the knees.
This suggests that our findings are 'joint specific' rather than 'patient specific'. Table 1 shows the findings in the group as a whole, indicating the heterogeneity found in rheumatoid joints.
When the SF findings from the 27 joints serially aspirated were considered two groups emerged: a tp<O0OS (Fisher's exact probability test).
proportion of total distinct population with high ragocyte proportions (11 joints) and a second population with low ragocyte proportions (15 joints). Table 2 shows the clinical details for these two groups. One joint had low ragocytes on first aspiration and high ragocytes on second aspiration and was therefore in neither group, and excluded for analysis. Comparison of clinical outcome in these subgroups showed that the joints with a high ragocyte proportion had a significantly poorer outlook when the end point of joint replacement or synovectomy was considered, despite a shorter mean length of disease. Thus a high proportion of ragocytes was associated with a more rapidly progressive disease in the aspirated joint if treatment did not reverse the ragocyte proportion.
Discussion
The heterogeneity of rheumatoid synovial fluids is confirmed in this study, our results being similar to others published.' -3 In any one inflamed joint there is remarkable similarity in the SF cellular response when the joint relapses in the course of the disease, no matter what the treatment, but especially if treatment remains unaltered. This is only true for proportions of cell types not their absolute numbers. Previous case reports have suggested similar cell populations during the course of the disease in rheumatoid effusions, but we have studied this formally for the first time.7 8 The reasons for the stability of these results are not clear, but this stability suggests that the pathogenic mechanisms sustaining the inflammatory response in the joint remain constant although the intensity of the response varies. Subgroups of RA joints emerge when serial SF cytology is performed. There are joints that sustain a predominance of ragocytes in their SF and others with a paucity of ragocytes. Conversely, independent of their ragocyte proportion, there are joints which have either a polymorph or lymphocyte predominance. In our study the lymphocyte predominant joints (>50% lymphocytes as a proportion of total leucocytes on both aspirations) are few (four of 27) and therefore have not been compared with the polymorph predominant joints in terms of clinical outcome.
The poorer clinical outcome in the ragocyte predominant group (>50% ragocytes as a proportion of total leucocytes on both aspirations) may be related to the nature of the ragocyte and subsequent events within the joint. Ragocytes are described as being leucocytes with intracytoplasmic granules. 4 We conclude that by studying SF cytology from RA joints with relapsing disease, subgroups based upon these findings can be delineated. In addition, this subgrouping identifies joints which fare worse over a period of time. Our study by its very nature can comment only on prognosis in RA joints necessitating (because of clinical relapse) reaspiration. Whether the ragocyte is an indicator of prognosis at a single point in time needs further study, but, if this is found to be so, our results suggest that the possible prognosis for a joint can be obtained after disease duration of six months (Table 2 ). In addition, the joints in our study were reaspirated in a relatively short space of time. A longer term study is required to examine whether our findings hold true for joints with a longer interval between relapse.
